BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04152863-completion@plaintrial.com
DTSTAMP:20261029T024258Z
DTSTART;VALUE=DATE:20230712
SUMMARY:Efficacy\, Safety\, and Tolerability of Gebasaxturev (V937) Adminis
 tered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus 
 Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V93
 7-011) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04152863
URL:https://plaintrial.com/trial/NCT04152863
END:VEVENT
END:VCALENDAR